ID

36603

Description

High Dose Versus Routine Dose Icotinib in Advanced Non-small Cell Lung Cancer Patients With Stable Disease; ODM derived from: https://clinicaltrials.gov/show/NCT02027090

Link

https://clinicaltrials.gov/show/NCT02027090

Keywords

Versions (1)
  1. 5/26/19 5/26/19 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

May 26, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Non-small Cell Lung Cancer NCT02027090

English

Eligibility Non-small Cell Lung Cancer NCT02027090

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically or cytologically confirmed stage iiib/iv lung cancer(exclude patients confirmed by sputum cytology);
Description

Carcinoma of lung TNM clinical staging | Sputum Cytology Excluded

Data type

boolean

Alias
UMLS CUI [1,1]
C0684249
UMLS CUI [1,2]
C3258246
UMLS CUI [2,1]
C1521752
UMLS CUI [2,2]
C0332196
pretreated with at least 1 platinum-based chemotherapy;
Description

Pretreatment Chemotherapy Platinum-Based

Data type

boolean

Alias
UMLS CUI [1,1]
C3539076
UMLS CUI [1,2]
C0392920
UMLS CUI [1,3]
C1514162
no previous targeted treatment such as gefitinib, erlotinib;
Description

Targeted Therapy Absent | Gefitinib Absent | Erlotinib Absent

Data type

boolean

Alias
UMLS CUI [1,1]
C2985566
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C1122962
UMLS CUI [2,2]
C0332197
UMLS CUI [3,1]
C1135135
UMLS CUI [3,2]
C0332197
with a measurable disease(longest diameters >=10mm with spiral computed tomography (ct)and >=20mm with conventional ct) according to recist criteria;
Description

Measurable Disease | Longest Diameter Spiral CT | Longest Diameter CT

Data type

boolean

Alias
UMLS CUI [1]
C1513041
UMLS CUI [2,1]
C0552406
UMLS CUI [2,2]
C0860888
UMLS CUI [3,1]
C0552406
UMLS CUI [3,2]
C0040405
who performance status(ps)<= 2;
Description

WHO performance status scale

Data type

boolean

Alias
UMLS CUI [1]
C1298650
adequate organ functions;
Description

Organ function

Data type

boolean

Alias
UMLS CUI [1]
C0678852
signed and dated informed consent before the start of specific protocol procedures.
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
allergic to icotinib;
Description

Hypersensitivity Icotinib

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C2604307
patients with metastatic brain tumors with symptoms;
Description

Symptoms Metastatic malignant neoplasm to brain

Data type

boolean

Alias
UMLS CUI [1,1]
C1457887
UMLS CUI [1,2]
C0220650
experience of anti-egfr(the epidermal growth factor receptor) monoclonal antibody or small molecular compounds therapy such as gefitinib, erlotinib or cetuximab;
Description

Anti-EGFR Monoclonal Antibody | Small Molecule Compound Therapy | gefitinib | erlotinib | cetuximab

Data type

boolean

Alias
UMLS CUI [1]
C4522190
UMLS CUI [2,1]
C1328819
UMLS CUI [2,2]
C1706082
UMLS CUI [2,3]
C0087111
UMLS CUI [3]
C1122962
UMLS CUI [4]
C1135135
UMLS CUI [5]
C0995188
severe systemic disease out of control such as unstable or uncompensated respiratory,cardiac,liver,renal diseases.
Description

Systemic disease Severe Uncontrolled | Respiration Disorder Unstable | Heart Disease Unstable | Liver disease Unstable | Kidney Disease Unstable | Respiration Disorder Uncompensated | Heart Disease Uncompensated | Liver disease Uncompensated | Kidney Disease Uncompensated

Data type

boolean

Alias
UMLS CUI [1,1]
C0442893
UMLS CUI [1,2]
C0205082
UMLS CUI [1,3]
C0205318
UMLS CUI [2,1]
C0035204
UMLS CUI [2,2]
C0443343
UMLS CUI [3,1]
C0018799
UMLS CUI [3,2]
C0443343
UMLS CUI [4,1]
C0023895
UMLS CUI [4,2]
C0443343
UMLS CUI [5,1]
C0022658
UMLS CUI [5,2]
C0443343
UMLS CUI [6,1]
C0035204
UMLS CUI [6,2]
C0205433
UMLS CUI [7,1]
C0018799
UMLS CUI [7,2]
C0205433
UMLS CUI [8,1]
C0023895
UMLS CUI [8,2]
C0205433
UMLS CUI [9,1]
C0022658
UMLS CUI [9,2]
C0205433
Back to the top of the page

Similar models

Eligibility Non-small Cell Lung Cancer NCT02027090

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Carcinoma of lung TNM clinical staging | Sputum Cytology Excluded
Item
histologically or cytologically confirmed stage iiib/iv lung cancer(exclude patients confirmed by sputum cytology);
boolean
C0684249 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
C1521752 (UMLS CUI [2,1])
C0332196 (UMLS CUI [2,2])
Pretreatment Chemotherapy Platinum-Based
Item
pretreated with at least 1 platinum-based chemotherapy;
boolean
C3539076 (UMLS CUI [1,1])
C0392920 (UMLS CUI [1,2])
C1514162 (UMLS CUI [1,3])
Targeted Therapy Absent | Gefitinib Absent | Erlotinib Absent
Item
no previous targeted treatment such as gefitinib, erlotinib;
boolean
C2985566 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C1122962 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C1135135 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
Measurable Disease | Longest Diameter Spiral CT | Longest Diameter CT
Item
with a measurable disease(longest diameters >=10mm with spiral computed tomography (ct)and >=20mm with conventional ct) according to recist criteria;
boolean
C1513041 (UMLS CUI [1])
C0552406 (UMLS CUI [2,1])
C0860888 (UMLS CUI [2,2])
C0552406 (UMLS CUI [3,1])
C0040405 (UMLS CUI [3,2])
WHO performance status scale
Item
who performance status(ps)<= 2;
boolean
C1298650 (UMLS CUI [1])
Organ function
Item
adequate organ functions;
boolean
C0678852 (UMLS CUI [1])
Informed Consent
Item
signed and dated informed consent before the start of specific protocol procedures.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Hypersensitivity Icotinib
Item
allergic to icotinib;
boolean
C0020517 (UMLS CUI [1,1])
C2604307 (UMLS CUI [1,2])
Symptoms Metastatic malignant neoplasm to brain
Item
patients with metastatic brain tumors with symptoms;
boolean
C1457887 (UMLS CUI [1,1])
C0220650 (UMLS CUI [1,2])
Anti-EGFR Monoclonal Antibody | Small Molecule Compound Therapy | gefitinib | erlotinib | cetuximab
Item
experience of anti-egfr(the epidermal growth factor receptor) monoclonal antibody or small molecular compounds therapy such as gefitinib, erlotinib or cetuximab;
boolean
C4522190 (UMLS CUI [1])
C1328819 (UMLS CUI [2,1])
C1706082 (UMLS CUI [2,2])
C0087111 (UMLS CUI [2,3])
C1122962 (UMLS CUI [3])
C1135135 (UMLS CUI [4])
C0995188 (UMLS CUI [5])
Systemic disease Severe Uncontrolled | Respiration Disorder Unstable | Heart Disease Unstable | Liver disease Unstable | Kidney Disease Unstable | Respiration Disorder Uncompensated | Heart Disease Uncompensated | Liver disease Uncompensated | Kidney Disease Uncompensated
Item
severe systemic disease out of control such as unstable or uncompensated respiratory,cardiac,liver,renal diseases.
boolean
C0442893 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0205318 (UMLS CUI [1,3])
C0035204 (UMLS CUI [2,1])
C0443343 (UMLS CUI [2,2])
C0018799 (UMLS CUI [3,1])
C0443343 (UMLS CUI [3,2])
C0023895 (UMLS CUI [4,1])
C0443343 (UMLS CUI [4,2])
C0022658 (UMLS CUI [5,1])
C0443343 (UMLS CUI [5,2])
C0035204 (UMLS CUI [6,1])
C0205433 (UMLS CUI [6,2])
C0018799 (UMLS CUI [7,1])
C0205433 (UMLS CUI [7,2])
C0023895 (UMLS CUI [8,1])
C0205433 (UMLS CUI [8,2])
C0022658 (UMLS CUI [9,1])
C0205433 (UMLS CUI [9,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial